All In Biotech

Drug Trial Radar · NCT06715683

A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants

An Open-label, Randomized, 2-Part, 4-Period, 2-Sequence, Fully Replicated Crossover Study to Assess the Comparative Bioavailability of BMS-986278 To-be-marketed Formulation Compared to the Phase 3 Clinical Trial Formulation in Healthy Participants

Last checked: Nov 19, 2026Latest source record: Apr 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

48

Actual

Start

Dec 12, 2024

Primary completion

Mar 16, 2025

Study completion Mar 16, 2025

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Dec 4, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a trial to evaluate the comparative bioavailability of BMS-986278 to-be-marketed formulation compared to the phase 3 clinical trial formulation in healthy participants.

Conditions

  • Healthy Volunteers

Interventions

  • BMS-986278 Batched method, Dose ADrug

    Specified dose on specified days

  • BMS-986278 Batched method, Dose BDrug

    Specified dose on specified days

  • BMS-986278 Continuous methodDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Observed Plasma Concentration (Cmax)Time frame: Up to Day 24
  2. Area Under the Concentration-time From Time Zero to Time Last Qualifiable Concentration (AUC(0-T))Time frame: Up to Day 24
  3. Area Under the Concentration-time From Time Zero Extrapolated to Infinite Time (AUC(INF))Time frame: Up to Day 24

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Anaheim Clinical Trials (ACT)

    Anaheim, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.